echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Drinking more coffee can reduce liver disease mortality by nearly half?

    Drinking more coffee can reduce liver disease mortality by nearly half?

    • Last Update: 2020-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: This study suggests that one million lives could be saved each year if moderate coffee consumption were generally encouraged globally to reduce the risk of premature death from liver disease.
    . Liver disease is one of the killers of human health, according to statistics, about 1 million people die of cirrhosis each year, about 740,000 people die of liver cancer caused by cirrhosis, accounting for more than 3.5% of the total annual death toll.
    in order to reduce the incidence and treatment burden of the disease, countries have launched vaccinations against hepatitis B and C and a variety of treatment strategies.
    A recent study by researchers from the University of Melbourne and St Vincent's Hospital in Australia found that increased per capita coffee intake has a beneficial effect on reducing liver-related mortality globally, reducing the number of deaths from liver cancer by hundreds of thousands if everyone in the world drinks at least two cups of coffee a day.
    study was published in the journal Alimentary Pharmacology and Therapeutics.
    For the study, researchers counted liver-related diseases and hepatitis B deaths in each country in the Global Burden of Disease (GBD) database in 2016, using public data from the International Coffee Organization to count the annual coffee consumption per capita in each country.
    then added the two sets of data to a model to estimate the potential impact of increased per capita coffee intake on global liver-related mortality.
    , a global map of per capita daily coffee intake, shows that globally, there were about 1.24 million liver-related deaths among people over 15 years of age in 2016, with a median liver disease mortality rate of 15 deaths per 100,000 people per year.
    Combined with coffee consumption, the model shows that if the global average coffee consumption exceeds two cups per day, the total number of liver-related deaths among people over 15 years of age will be reduced to at least about 715,000, avoiding about 42 per cent of deaths and preventing 7.8 liver-related deaths per 100,000 people per year.
    The actual number of liver-related deaths per capita coffee consumption in each region in 2016 and the predicted number of liver-related deaths of more than two or four cups per day, and if per capita coffee intake in all countries increases to four or more cups per day, the global total number of deaths will be reduced by at least 400,000 and 67% of liver-related deaths can be avoided, with a preventable rate of 12.1 liver-related deaths per 100,000 people per year.
    , in recent years it has been gradually discovered that drinking coffee improves the biochemistry of the liver and slows the development of cirrhosis.
    One of the largest high-quality prospective cohort studies to date, published in 2015, found that drinking two to three cups of coffee a day reduced the risk of cirrhosis by 38 percent, the risk of dying from the disease by 46 percent, and when four cups of coffee or more were drunk a day, the risk of cirrhosis was reduced by 41 percent and the risk of death by 71 percent.
    , the study suggests that if moderate coffee consumption were generally encouraged globally to reduce the risk of premature death from liver disease, one million lives could be saved each year.
    particularly outside Europe, where coffee consumption is low and the incidence of underlying liver disease is relatively high, the benefits of liver-related mortality are greater.
    resources: s1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.